Collectively, these findings demonstrate a strong role for SALL4 in gastric cancer angiogenesis through modulating the VEGF family and establishing a synergistic treatment via the exosomes-nano carrier system as a promising strategy for gastric cancer treatment (Fig. 9). Here, VEGFA is linked to gastric cancer.